期刊文献+

绒毛膜促性腺激素及其游离β亚单位对不良妊娠的诊断价值 被引量:4

Diagnostic value of β-HCG and fβ-HCG of adverse pregnancy
下载PDF
导出
摘要 目的探讨β绒毛膜促性腺激素(β-HCG)及其游离β亚单位(fβ-HCG)在不良妊娠中的诊断价值。方法运用化学发光分析技术分别检测早期不良妊娠患者(先兆流产组、稽留流产组、异位妊娠组)及正常妊娠孕妇(对照组)的血清β-HCG、fβ-HCG、黄体酮水平,计算各组48h后β-HCG的倍增率,对结果进行分析。结果与先兆流产组相比较,稽留流产组和异位妊娠组的β-HCG、fβ-HCG、黄体酮水平及β-HCG倍增率差异均有统计学意义(P<0.05)。稽留流产组与异位妊娠组之间各指标差异则无统计学意义(P>0.05)。结论β-HCG和fβ-HCG水平变化可反映不良妊娠。 Objective To explore the diagnostic value ofβ-human chorionic gonadotropin(β-HCG)and its freeβ-subunit(fβ-HCG)of adverse pregnancy.Methods Chemiluminescence technique was used for the detection of serum levels ofβ-HCG,fβ-HCG and progesterone in women with early adverse pregnancy(threatened abortion group,missed abortion group and ectopic pregnancy group)and normal pregnant women(control group),respectively.The 48 hdoubling rate ofβ-HCG of each group was calculated.And the results were analyzed.Results Comparing with threatened abortion group,there were significant differences in the levels ofβ-HCG,fβ-HCG,progesterone and doubling rate both of missed abortion group and ectopic pregnancy group(P〈0.05).However,there was no difference in these indicators between missed abortion group and ectopic pregnancy group(P〉0.05).Conclusion The changes ofβ-HCG and fβ-HCG can reflect adverse pregnancy.
出处 《国际检验医学杂志》 CAS 2014年第22期3030-3031,共2页 International Journal of Laboratory Medicine
基金 广东省人口和计划生育委员会科技基金资助项目(20120303) 佛山市医学类科技攻关项目(fs20120318)
关键词 Β-HCG fβ-HCG 黄体酮 不良妊娠 倍增率 β-HCG fβ-HCG adverse pregnancy progesterone doubling rate
  • 相关文献

参考文献16

二级参考文献106

共引文献114

同被引文献34

  • 1乐杰.妇产科学[M].7版.北京:人民卫生出版社,2010:366.
  • 2Sivalingam VN,Duncan WC,Kirk E,et al.Diagnosis and management of ectopic pregnancy[J].J Fam Plann Reprod Health Care,2011,37(4):231-240.
  • 3Veena P.Use of mifepristone along with methotrexate in medical management of unruptured ectopic pregnancy[J].J Obstet Gynaecol,2011,31(7):667-670.
  • 4Kirby JM,Cho KJ,Midia M.Image-guided intervention in management of complications of portal hypertension:more than TIPS for success[J].Radiographics,2013,33(5):1473-1496.
  • 5罗颂平,谈勇.中医妇科学[M].2版.北京:人民卫生出版社,2014:145-149.
  • 6Osmanagaoglu MA, Erdogan I, Eminagaoglu S, et al. The di agnogistic value of beta-human chorionic gonadotropin, pro- gesterone, CA125 in the prediction of abortions [J]. J Obstet Gynaecol, 2010, 30(3) :288-293.
  • 7Sivalingam VN, Duncan WC, Kirk E, et al. Diagnosis and management of ectopic pregnancy [J].J Fam Plann Reprod Health Care, 2011,37 (43 : 231-240.
  • 8Veena P. Use of mifepristone along with methotrexate in medical management of unruptured ectopic pregnancy[J].J Obstet Gynaecol,2011,31(7) :667-670.
  • 9Feng C, Chen ZY, Zhang J, et al. Clinical utility of serum re- productive hormones for the early diagnosis of ectopic preg- nancy in the first trimester [J].J Obstet Gynaecol Res, 2013, 39(2) : 528-535.
  • 10王秀萍,焦琳,郭红燕.人绒毛膜促性腺激素的临床应用进展[J].药学服务与研究,2010,10(3):185-189. 被引量:27

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部